CD47 and head and neck squamous cell carcinoma: Such observations further suggest that TTP may be involved in the development of radioresistance in HNSCC and that it could constitute a potential biomarker for predicting the efficacy of CD47 antibody-based treatment in recurrent HNSCC following radiotherapy [78].